SAN FRANCISCO — Investors attending the J.P. Morgan Healthcare conference here still work market hours, which means waking up well before dawn to catch all the biotech news hitting the wires at a reasonable hour on the East Coast.

The news flow announced Sunday afternoon and Monday morning had mostly incremental updates and not necessarily positive ones, leaving the Nasdaq Biotech Index essentially flat. It’s also raining here. The JPM investor sentiment meter might have a hard time ticking past dreary.

Unlock this article by subscribing to STAT Plus. Try it FREE for 30 days!

GET STARTED

What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy